Title : Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.

Pub. Date : 2009 Feb

PMID : 18474393






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Similarly, peak thrombin levels were reduced in patients treated with warfarin (-18%+/-7%, p=0.049) and aspirin/warfarin (-19%+/-5%, p=0.029), whereas an increase (12%+/-4%, p=0.029) occurred during aspirin treatment alone. Aspirin coagulation factor II, thrombin Homo sapiens
2 Similarly, peak thrombin levels were reduced in patients treated with warfarin (-18%+/-7%, p=0.049) and aspirin/warfarin (-19%+/-5%, p=0.029), whereas an increase (12%+/-4%, p=0.029) occurred during aspirin treatment alone. Aspirin coagulation factor II, thrombin Homo sapiens